Alejandro Nuño Ayala

  • Current company Unima
  • Location Mexico
  • Industry Healthcare

A clean bill of health shouldn’t cost an arm and a leg. For the rural poor in developing countries, doctors are hard to come by and diagnosing diseases requires sending away tests to lab facilities – a costly and time-intensive ordeal. Unima is lowering the cost and time to access medical support with Signatural, a diagnostic technology that costs consumers US$1 and takes less than 15 minutes to diagnose a disease. As the first Mexican company to participate in Y Combinator, Unima has developed tests for HIV, TB, and influenza, and is currently undergoing clinical trials to commercialize its first products in late 2017. With over three billion people in developing countries living without access to timely diagnostics, Unima is poised to tackle the US$15 billion point-of-care diagnostics market and help those at the bottom of the pyramid battle infectious diseases

Stay up to date on our entrepreneurs, events, research and more.